Outset Medical, Inc.
OM
$13.80
-$0.405-2.85%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 46.19% | 35.45% | 33.58% | 39.50% | 21.78% |
Total Depreciation and Amortization | -21.48% | -11.37% | -2.77% | -5.12% | -2.84% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -54.10% | 42.00% | -35.20% | -34.72% | 24.77% |
Change in Net Operating Assets | 161.01% | 18.65% | -47.60% | -145.10% | -333.42% |
Cash from Operations | 85.53% | 44.10% | 32.54% | 39.50% | -18.31% |
Capital Expenditure | -143.33% | 65.25% | 95.92% | 49.49% | 84.91% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -179.03% | -32.86% | 342.01% | -46.81% | 39.76% |
Cash from Investing | -180.02% | -32.27% | 361.70% | -46.74% | 43.41% |
Total Debt Issued | -- | 47.72% | -100.00% | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -100.00% | -80.44% | -100.00% | -97.05% | -92.62% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -598.70% | -18.88% | -102.82% | -97.05% | -92.62% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -739.96% | -32.35% | 181.66% | -4,924.18% | 28,315.00% |